The CHL1 gene, primarily related to neuronal development and function, does not have established direct pharmacogenetic interactions with drugs that affect drug metabolism or pharmacokinetics. However, alterations in CHL1 might indirectly affect the response to neuropsychiatric treatments by influencing disease pathophysiology or neuronal responses.